Clinical Trial Update: Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating Niraparib in combination with Ipilimumab or Nivolumab in pancreatic adenocarcinoma after platinum-based chemotherapy; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Niraparib (Niraparib)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-03